| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | FIMM | pan-cancer | AAC | 0.097 | 0.5 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.027 | 0.5 |
| mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | -0.038 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | pifithrin-alpha | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | EHT 1864 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | 0.027 | 0.5 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |